Evidence map›Paper›PMID 40246883›Full record

ArticleScientific reports2025

Fragile X messenger ribonucleoprotein 1 (FMRP) regulates glycolytic gene expression under chronic hypoxia in HCT116 cells.

Yoko Ogura, Xiaoning Sun, Zaijun Zhang, Kentaro Kawata, Jinyu Wu, Ryuma Matsubara, Atsuko Nakanishi Ozeki, Kenzui Taniue, Rena Onoguchi-Mizutani, Shungo Adachi and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yoko Ogura *Department of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan.
Xiaoning Sun *Advanced Interdisciplinary Studies, Engineering Department, The University of Tokyo, Tokyo, Japan.
Zaijun Zhang *Department of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan.
Kentaro KawataIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan. kawata.kentaro@aist.go.jp.
Jinyu WuDepartment of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033, Japan.
Ryuma MatsubaraIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Atsuko Nakanishi OzekiIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Kenzui TaniueIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Rena Onoguchi-MizutaniIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Shungo AdachiDepartment of Proteomics, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
Koh NakayamaDepartment of Pharmacology, School of Medicine, Asahikawa Medical University, Hokkaido, 078-8510, Japan.
Nobuhito GodaDepartment of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, 162-8480, Japan.
Nobuyoshi AkimitsuIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan. akimitsu@ric.u-tokyo.ac.jp.

Funding

Japan Society for the Promotion of Science 17KK0163Japan Society for the Promotion of Science 19K16635
6 · The paper itself

Abstract

Oxygen shortage, known as hypoxia, occurs commonly in both physiological and pathological conditions. Transcriptional regulation by hypoxia-inducible factors is a dominant regulatory mechanism controlling hypoxia-responsive genes during acute hypoxia; however, recent studies suggest that post-transcriptional regulation, including RNA degradation, also involves hypoxia-induced gene expression during the chronic hypoxia. In this study, we developed a method to quantify the contributions of RNA synthesis and degradation to differential gene expression, and identified 102 genes mainly regulated via RNA degradation under chronic hypoxia in HCT116 cells. Bioinformatics analysis showed that the genes mainly regulated by RNA degradation were involved in glycolysis. We examined changes in the RNA-binding ability of RNA-binding proteins by RNA interactome capture and statistical analysis using public databases. We identified fragile X messenger ribonucleoprotein 1 (FMRP) as an RNA-binding protein involved in the chronic hypoxia-induced increase in mRNAs encoding rate-limiting enzymes. This study emphasizes the importance of post-transcriptional gene regulation under chronic hypoxia in HCT116 cells.

Indexed as

Gene Expression Regulation, NeoplasticGlycolysisHypoxiaCell HypoxiaComputational BiologyHCT116 CellsHumansRNA, MessengerRNA StabilityRNA, MessengerGlycolysisHypoxiaMetabolic labelingRNA degradationRNA synthesis

Identifiers

PMID40246883
PMCPMC12006372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.